SIRT1 Activation Suppresses Corneal Endothelial–Mesenchymal Transition via the TGF-β/Smad2/3 Pathway

Yi Yu, Ruilin Guo, Jie Ling, Chenjia Xu, Minglu Ma, Xiaojuan Dong, Jing Wu, Ting Huang · 2024

Read SIRT1 Activation Suppresses Corneal Endothelial–Mesenchymal Transition via the TGF-β/Smad2/3 Pathway by Yi Yu, Ruilin Guo, Jie Ling, Chenjia Xu, Minglu Ma, Xiaojuan Dong, Jing Wu, Ting Huang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11727023.txt.

Description

Yi Yu and seven co-authors showed that switching on a longevity enzyme protects the cornea's inner lining in a 2024 paper. After injury, corneal endothelial cells can morph into scar-like mesenchymal cells, clouding the window they should keep clear. The switch is driven by the TGF-beta pathway, and the enzyme SIRT1 is one of its brakes.

In injured rats and in human cells in dishes, activating SIRT1 with resveratrol restored transparency faster, cut scar markers, and preserved the cells' proper identity markers. Blocking SIRT1 reversed every benefit. The enzyme also engaged directly with the pathway's Smad messengers. The authors propose SIRT1 activation as a way to keep corneal cells themselves after damage.

Catalog record

CREATORYi Yu, Ruilin Guo, Jie Ling, Chenjia Xu, Minglu Ma, Xiaojuan Dong, Jing Wu, Ting Huang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11727023

Browse the full library · About the Tower of Babel